Comparison effect of Propofol-Fentanyl with Propofol-Ketamine for sedation in patients undergoing ERCP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014031316976N1

Enrollment

Registered

2014-04-15

Start date

2014-06-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Endoscopic Retrograde Cholangio Pancreatography)ERCP. Fluoroscopy of Biliary and Pancreatic Ducts using Low Osmolar Contrast

Interventions

Intervention 1: Drugs: 1-Propofol: Dose: 0.5mg/kg Number of using: Once Factory name: Astra Zeneca Country's Name:India Location prescribed: Intravascular Administration time: At the beginning

Treatment - Drugs

Drugs: 1-Propofol: Dose: 0.5mg/kg Number of using: Once Factory name: Astra Zeneca Country's Name:India Location prescribed: Intravascular Administration time: At the beginning of the pr

Drugs: 1-Propofol: Dose: 0.5mg/kg Number of using: Once Factory name: Astra Zeneca Country's Name:India Location prescribed: Intravascular Administration time: At the beginning of the pro

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: admitted patients for diagnostic and therapeutic ERCP in Imam Khomeini hospital; 18 to 65 years old; anesthesia risk of 1, 2 (According to American society of anesthesiologist's classification). Exclusion criteria: patient refuse; under 18 and over 65 years old; a history of drug abuse; sensitivity to egg; contraindication of Fentanyl or Ketamine.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sedation Score. Timepoint: Four times, during procedure. Method of measurement: Ramsay Sedation Score.	—

Secondary

Measure	Time frame
Pain. Timepoint: One hour after procedure. Method of measurement: Visual Analogue Scale.;Nausea. Timepoint: One hour after procedure. Method of measurement: Zero for not having nausea, One for mild nausea, Two for moderate nausea and Three for sever nausea.;Vomiting. Timepoint: One hour after procedure. Method of measurement: Zero for the patients not experiencing vomiting, 1 for the little vomiting, 2 for vomiting gastric contents and 3 for vomiting food particles.	—

Measure

Time frame

Pain. Timepoint: One hour after procedure. Method of measurement: Visual Analogue Scale.;Nausea. Timepoint: One hour after procedure. Method of measurement: Zero for not having nausea, One for mild nausea, Two for moderate nausea and Three for sever nausea.;Vomiting. Timepoint: One hour after procedure. Method of measurement: Zero for the patients not experiencing vomiting, 1 for the little vomiting, 2 for vomiting gastric contents and 3 for vomiting food particles.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSanaz Noorizade

Ahvaz Jundishapur University of Medical Sciences

noorizade.s@ajums.ac.ir; mostafafatahi777@gmail.com+98 61 1432 5879

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026